CD47 and cancer: Through an analysis of data obtained from a screening model focused on the macrophage‐mediated killing effect, two cardiac glycosides (CGs), ouabain and digoxin, are shown to increase the capacity of macrophages to kill cancer cells after combination with CD47 antibody.